Literature DB >> 8031149

The bifunctional cytosolic 5'-nucleotidase: regulation of the phosphotransferase and nucleotidase activities.

R Pesi1, M Turriani, S Allegrini, C Scolozzi, M Camici, P L Ipata, M G Tozzi.   

Abstract

The cytosolic 5'-nucleotidase specific for IMP, GMP, and their deoxyderivatives has been purified approximately 1000 times from calf thymus. The enzyme, in the presence of a suitable nucleoside, can act as a phosphotransferase, catalyzing the transfer of the phosphate moiety from a nucleoside monophosphate donor to a nucleoside acceptor, thus operating as an interconverting activity. This phosphorylating activity has drawn the attention of several research groups because the cytosolic 5'-nucleotidase represents the only cellular enzyme able to phosphorylate inosine and guanosine analogs, which are not substrates of known cellular nucleoside kinases. In this paper, we report the kinetic parameters of the bifunctional enzyme and its response to variations in adenylate energy charge. The results seem to indicate that in the presence of physiological concentrations of ATP and phosphate, the enzyme behaves mainly as a phosphotransferase, its activity being dependent only on the availability of a suitable nucleoside.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031149     DOI: 10.1006/abbi.1994.1282

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  18 in total

1.  Invited Lectures : Overviews Purinergic signalling: past, present and future.

Authors: 
Journal:  Purinergic Signal       Date:  2006-05-15       Impact factor: 3.765

2.  Mechanism of the reaction catalysed by cytosolic 5'-nucleotidase/phosphotransferase: formation of a phosphorylated intermediate.

Authors:  C Baiocchi; R Pesi; M Camici; R Itoh; M Grazi Tozzi
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

Review 3.  Genetics and mechanisms of NT5C2-driven chemotherapy resistance in relapsed ALL.

Authors:  Chelsea L Dieck; Adolfo Ferrando
Journal:  Blood       Date:  2019-03-25       Impact factor: 22.113

4.  Bovine cytosolic IMP/GMP-specific 5'-nucleotidase: cloning and expression of active enzyme in Escherichia coli.

Authors:  S Allegrini; R Pesi; M G Tozzi; C J Fiol; R B Johnson; S Eriksson
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

5.  Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with acute myeloid leukemia.

Authors:  Amit K Mitra; Kristine R Crews; Stanley Pounds; Xueyuan Cao; Tanya Feldberg; Yogita Ghodke; Varsha Gandhi; William Plunkett; M Eileen Dolan; Christine Hartford; Susana Raimondi; Dario Campana; James Downing; Jeffrey E Rubnitz; Raul C Ribeiro; Jatinder K Lamba
Journal:  J Pharmacol Exp Ther       Date:  2011-06-28       Impact factor: 4.030

6.  Phosphorylation of ribavirin and viramidine by adenosine kinase and cytosolic 5'-nucleotidase II: Implications for ribavirin metabolism in erythrocytes.

Authors:  Jim Zhen Wu; Gary Larson; Heli Walker; Jae Hoon Shim; Zhi Hong
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  ADNP differentially interact with genes/proteins in correlation with aging: a novel marker for muscle aging.

Authors:  Oxana Kapitansky; Illana Gozes
Journal:  Geroscience       Date:  2019-07-01       Impact factor: 7.713

8.  Expression and functional activity of nucleoside transporters in human choroid plexus.

Authors:  Zoran B Redzic; Slava A Malatiali; Danica Grujicic; Aleksandra J Isakovic
Journal:  Cerebrospinal Fluid Res       Date:  2010-01-11

9.  NMDA receptor-mediated extracellular adenosine accumulation is blocked by phosphatase 1/2A inhibitors.

Authors:  Yin Lu; Paul A Rosenberg
Journal:  Brain Res       Date:  2007-05-04       Impact factor: 3.252

10.  Structure and Mechanisms of NT5C2 Mutations Driving Thiopurine Resistance in Relapsed Lymphoblastic Leukemia.

Authors:  Chelsea L Dieck; Gannie Tzoneva; Farhad Forouhar; Zachary Carpenter; Alberto Ambesi-Impiombato; Marta Sánchez-Martín; Renate Kirschner-Schwabe; Scott Lew; Jayaraman Seetharaman; Liang Tong; Adolfo A Ferrando
Journal:  Cancer Cell       Date:  2018-07-09       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.